BerandaGLPG • AMS
add
Galapagos NV
Tutup sebelumnya
€25,84
Rentang hari
€25,52 - €26,44
Rentang tahun
€22,00 - €39,00
Kapitalisasi pasar
1,75Â M EUR
Volume Rata-Rata
102,66Â rb
Rasio P/E
8,40
Hasil dividen
-
Bursa utama
AMS
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (EUR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 59,85Â jt | -50,14% |
Biaya operasional | 21,09Â jt | 112,58% |
Laba bersih | -50,43Â jt | -295,24% |
Margin laba bersih | -84,26 | -491,54% |
Penghasilan per saham | -0,74 | -289,74% |
EBITDA | -48,48Â jt | -86,02% |
Tarif pajak efektif | 1,16% | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,34Â M | -12,41% |
Total aset | 4,17Â M | -6,27% |
Total liabilitas | 1,31Â M | -28,43% |
Total ekuitas | 2,86 M | — |
Saham yang beredar | 65,94 jt | — |
Harga terhadap nilai buku | 0,60 | — |
Tingkat pengembalian aset | -3,21% | — |
Tingkat pengembalian modal | -4,69% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -50,43Â jt | -295,24% |
Kas dari operasi | -71,79Â jt | 39,58% |
Kas dari investasi | 56,56Â jt | -69,02% |
Kas dari pembiayaan | -1,09Â jt | 47,41% |
Perubahan kas bersih | -16,80Â jt | -127,39% |
Arus kas bebas | -66,59Â jt | 24,78% |
Tentang
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Didirikan
1999
Situs
Karyawan
683
